Loading...
Targeting survival pathways in chronic myeloid leukaemia stem cells
Chronic myeloid leukaemia (CML) is a clonal myeloproliferative disorder characterized by the presence of a fusion oncogene BCR-ABL, which encodes a protein with constitutive TK activity. The implementation of tyrosine kinase inhibitors (TKIs) marked a major advance in CML therapy; however, there are...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Publishing Ltd
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3753830/ https://ncbi.nlm.nih.gov/pubmed/23517124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.12183 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|